摘要 |
According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A- A or, particularly, the A receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy or Het; Cy represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy group is optionally substituted by one or more R substituents; Het represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy or Het; Cy represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy group is optionally substituted by one or more R substituents; Het represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which Het group is optionally substituted by one or more R substituents. |
申请人 |
HEPTARES THERAPEUTICS LIMITED |
发明人 |
CONGREVE, MILES STUART;ANDREWS, STEPHEN PHILIPPE;MASON, JONATHAN STEPHEN;RICHARDSON, CHRISTINE MARY;BROWN, GILES ALBERT |